Algorithms for molecular testing in solid tumours
Surveillance de la santé et des maladies
Téléchargement 505.84 KoPeer reviewed scientific article
Anglais
SCIENSANO
Auteurs
Aline Hébrant [2]; M Lammens [3]; C Van den Broeck [4]; N. D’Haene [5]; J Van den Oord [6]; A. Vanderstichele [7]; A Dendooven [8]; P Neven [9]; K Punie [10]; G Floris [11]; J Van der Meulen [12]; H A Poirel [13]; C Dooms [14]; S Rottey [15]; T Boterberg [16]; L Brochez [17]; MC Burlacu [18]; G Costante [19]; D Creytens [20]; De Paepe, P [21]; R De Pauwn [22]; B Decallonne [23]; F Dedeurwaerdere [24]; H Denys [25]; L Ferdinande [26]; R Forsyth [27]; M Garmyn [28]; T Gevaert [29]; J De Grève [30]; E Govaerts [31]; E Hauben [32]; J Kerger [33]; O Kholmanskikh Van Criekingen [34]; V Kruse [35]; Y Lalami [36]; L Lapeire [37]; P Lefesvre [38]; JP Machiels [39]; B Maes [40]; G Martens [41]; M Remmelink [42]; I Salmon [43]; R Sciot [44]; S Tejpar [45]; K Van de Vijver [46]; L Van de Voorde [47]; I Van den Berghe [48]; A Van den Bruel [49]; K Vandecasteele [50]; L Vanwalleghem [51]; K Vermaelen [52]; R Salgado [53]; E Wauters [54]; B Weynand [55]; Els Van Valckenborgh [56]; Gordana Raicevic [57]; Marc Van den Bulcke [58]; P Pauwels [59]Mots-clés
Résumé:
In order to advise the Federal Government on the reimbursement of molecular tests related to Personalised Medicine in Oncology, the Commission of Personalised Medicine (ComPerMed), represented by Belgian experts, has developed a methodology to classify molecular testing in oncology. The different molecular tests per cancer type are represented in algorithms and are annotated with a test level reflecting their relevance based on current guidelines, drug approvals and clinical data. The molecular tests are documented with recent literature, guidelines and a brief technical description. This m…